Apellis Pharmaceuticals, Inc. ($APLS)
Filing Information
| Accession Number | 0001492422-26-000081 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 5, 2026 |
| Document Date | Feb 3, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
17,680
Total Value
$33,238.40
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 3, 2026 | Exercise/Conversion | 8,840 | $3.76 | $33,238.40 | 490,837 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Feb 3, 2026 | Exercise/Conversion | 8,840 | $0.00 | $0.00 | 0 | Direct | โ | View Details |